Acrigen Biosciences

About:

Acrigen Biosciences is dedicated to making gene editing safe.

Website: https://www.acrigen.com/

Twitter/X: acrigenbio

Top Investors: National Science Foundation, Alexandria Venture Investments, Dolby Family Ventures, Red Tree Venture Capital, Berkeley Catalyst Fund (BCF)

Description:

Acrigen Biosciences is dedicated to making gene editing safe. It develops technologies to improve efficiency and enhance the safety of CRISPR-Cas based gene editing. CRISPR-Cas system which enables the precise enzymatic editing of genes is one of the most exciting and promising techniques to be developed in the last few years with the capability to prevent or cure many devastating diseases. It was founded in 2019 and is headquartered in Berkeley, California.